title: A health impact assessment of increased aspirin use in Wales.
abstract: OBJECTIVE
  To estimate the likely magnitude of health impact if all individuals at increased risk of cardiovascular events in Wales (total population 2.9 million) took low-dose aspirin.
  
  
  METHODS
  Data from a variety of different sources were collected and systematically combined using simple methods and conservative assumptions.
  
  
  RESULTS
  Aspirin may reduce cardiovascular mortality by 2-25% and avoid 330-3250 deaths per annum after allowing for a small number of fatal undesirable effects.
  
  
  CONCLUSIONS
  Wales might lead the way in developing an aspirin programme.
authors.affiliation: Welsh Aspirin Group Secretary, 41 Ffordd Beck, Gowerton, Swansea, Wales SA4 3GE, UK. morgan@ffordbeck.fsnet.co.uk
authors.forename: G
authors.initials: G
authors.lastname: Morgan
mesh_terms: D001241:Aspirin / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012307:Risk Factors; D014852:Wales / Q000453:epidemiology
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin